{
    "title": "Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.",
    "abst": "More than 50% of Lobund-Wistar (L-W) strain rats developed large, palpable prostate adenocarcinomas (PAs) following treatments with N-nitroso-N-methylurea (CAS: 684-93-5) and testosterone propionate [(TP) CAS: 57-85-2], and most of the tumor-bearing rats manifested metastatic lesions. The incubation periods averaged 10.6 months. Within the same timeframe, no L-W rat developed a similar palpable PA when treated only with TP. In L-W rats, TP acted as a tumor enhancement agent, with primary emphasis on the development of prostate cancer.",
    "title_plus_abst": "Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. More than 50% of Lobund-Wistar (L-W) strain rats developed large, palpable prostate adenocarcinomas (PAs) following treatments with N-nitroso-N-methylurea (CAS: 684-93-5) and testosterone propionate [(TP) CAS: 57-85-2], and most of the tumor-bearing rats manifested metastatic lesions. The incubation periods averaged 10.6 months. Within the same timeframe, no L-W rat developed a similar palpable PA when treated only with TP. In L-W rats, TP acted as a tumor enhancement agent, with primary emphasis on the development of prostate cancer.",
    "pubmed_id": "3461217",
    "entities": [
        [
            28,
            43,
            "prostate cancer",
            "Disease",
            "D011471"
        ],
        [
            85,
            107,
            "N-nitroso-N-methylurea",
            "Chemical",
            "D008770"
        ],
        [
            112,
            124,
            "testosterone",
            "Chemical",
            "D013739"
        ],
        [
            201,
            225,
            "prostate adenocarcinomas",
            "Disease",
            "D011471"
        ],
        [
            227,
            230,
            "PAs",
            "Disease",
            "D011471"
        ],
        [
            258,
            280,
            "N-nitroso-N-methylurea",
            "Chemical",
            "D008770"
        ],
        [
            301,
            324,
            "testosterone propionate",
            "Chemical",
            "D043343"
        ],
        [
            327,
            329,
            "TP",
            "Chemical",
            "D043343"
        ],
        [
            362,
            367,
            "tumor",
            "Disease",
            "D009369"
        ],
        [
            524,
            526,
            "PA",
            "Disease",
            "D011471"
        ],
        [
            550,
            552,
            "TP",
            "Chemical",
            "D043343"
        ],
        [
            567,
            569,
            "TP",
            "Chemical",
            "D043343"
        ],
        [
            581,
            586,
            "tumor",
            "Disease",
            "D009369"
        ],
        [
            650,
            665,
            "prostate cancer",
            "Disease",
            "D011471"
        ]
    ],
    "split_sentence": [
        "Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.",
        "More than 50% of Lobund-Wistar (L-W) strain rats developed large, palpable prostate adenocarcinomas (PAs) following treatments with N-nitroso-N-methylurea (CAS: 684-93-5) and testosterone propionate [(TP) CAS: 57-85-2], and most of the tumor-bearing rats manifested metastatic lesions.",
        "The incubation periods averaged 10.6 months.",
        "Within the same timeframe, no L-W rat developed a similar palpable PA when treated only with TP.",
        "In L-W rats, TP acted as a tumor enhancement agent, with primary emphasis on the development of prostate cancer."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D011471\tDisease\tprostate cancer\tProduction of autochthonous <target> prostate cancer </target> in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone .",
        "D008770\tChemical\tN-nitroso-N-methylurea\tProduction of autochthonous prostate cancer in Lobund-Wistar rats by treatments with <target> N-nitroso-N-methylurea </target> and testosterone .",
        "D013739\tChemical\ttestosterone\tProduction of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and <target> testosterone </target> .",
        "D011471\tDisease\tprostate adenocarcinomas\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable <target> prostate adenocarcinomas </target> ( PAs ) following treatments with N-nitroso-N-methylurea ( CAS : 684 - 93 - 5 ) and testosterone propionate [ ( TP ) CAS : 57 - 85 - 2 ] , and most of the tumor-bearing rats manifested metastatic lesions .",
        "D011471\tDisease\tPAs\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable prostate adenocarcinomas ( <target> PAs </target> ) following treatments with N-nitroso-N-methylurea ( CAS : 684 - 93 - 5 ) and testosterone propionate [ ( TP ) CAS : 57 - 85 - 2 ] , and most of the tumor-bearing rats manifested metastatic lesions .",
        "D008770\tChemical\tN-nitroso-N-methylurea\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable prostate adenocarcinomas ( PAs ) following treatments with <target> N-nitroso-N-methylurea </target> ( CAS : 684 - 93 - 5 ) and testosterone propionate [ ( TP ) CAS : 57 - 85 - 2 ] , and most of the tumor-bearing rats manifested metastatic lesions .",
        "D043343\tChemical\ttestosterone propionate\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable prostate adenocarcinomas ( PAs ) following treatments with N-nitroso-N-methylurea ( CAS : 684 - 93 - 5 ) and <target> testosterone propionate </target> [ ( TP ) CAS : 57 - 85 - 2 ] , and most of the tumor-bearing rats manifested metastatic lesions .",
        "D043343\tChemical\tTP\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable prostate adenocarcinomas ( PAs ) following treatments with N-nitroso-N-methylurea ( CAS : 684 - 93 - 5 ) and testosterone propionate [ ( <target> TP </target> ) CAS : 57 - 85 - 2 ] , and most of the tumor-bearing rats manifested metastatic lesions .",
        "D009369\tDisease\ttumor\tMore than 50 % of Lobund-Wistar ( L-W ) strain rats developed large , palpable prostate adenocarcinomas ( PAs ) following treatments with N-nitroso-N-methylurea ( CAS : 684 - 93 - 5 ) and testosterone propionate [ ( TP ) CAS : 57 - 85 - 2 ] , and most of the <target> tumor </target> -bearing rats manifested metastatic lesions .",
        "D011471\tDisease\tPA\tWithin the same timeframe , no L-W rat developed a similar palpable <target> PA </target> when treated only with TP .",
        "D043343\tChemical\tTP\tWithin the same timeframe , no L-W rat developed a similar palpable PA when treated only with <target> TP </target> .",
        "D043343\tChemical\tTP\tIn L-W rats , <target> TP </target> acted as a tumor enhancement agent , with primary emphasis on the development of prostate cancer .",
        "D009369\tDisease\ttumor\tIn L-W rats , TP acted as a <target> tumor </target> enhancement agent , with primary emphasis on the development of prostate cancer .",
        "D011471\tDisease\tprostate cancer\tIn L-W rats , TP acted as a tumor enhancement agent , with primary emphasis on the development of <target> prostate cancer </target> ."
    ],
    "lines_lemma": [
        "D011471\tDisease\tprostate cancer\tproduction of autochthonous <target> prostate cancer </target> in lobund-wistar rat by treatment with n-nitroso-n-methylurea and testosterone .",
        "D008770\tChemical\tN-nitroso-N-methylurea\tproduction of autochthonous prostate cancer in lobund-wistar rat by treatment with <target> n-nitroso-n-methylurea </target> and testosterone .",
        "D013739\tChemical\ttestosterone\tproduction of autochthonous prostate cancer in lobund-wistar rat by treatment with n-nitroso-n-methylurea and <target> testosterone </target> .",
        "D011471\tDisease\tprostate adenocarcinomas\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable <target> prostate adenocarcinoma </target> ( pa ) follow treatment with n-nitroso-n-methylurea ( cas : 684 - 93 - 5 ) and testosterone propionate [ ( tp ) cas : 57 - 85 - 2 ] , and most of the tumor-bearing rat manifest metastatic lesion .",
        "D011471\tDisease\tPAs\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable prostate adenocarcinoma ( <target> pa </target> ) follow treatment with n-nitroso-n-methylurea ( cas : 684 - 93 - 5 ) and testosterone propionate [ ( tp ) cas : 57 - 85 - 2 ] , and most of the tumor-bearing rat manifest metastatic lesion .",
        "D008770\tChemical\tN-nitroso-N-methylurea\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable prostate adenocarcinoma ( pa ) follow treatment with <target> n-nitroso-n-methylurea </target> ( cas : 684 - 93 - 5 ) and testosterone propionate [ ( tp ) cas : 57 - 85 - 2 ] , and most of the tumor-bearing rat manifest metastatic lesion .",
        "D043343\tChemical\ttestosterone propionate\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable prostate adenocarcinoma ( pa ) follow treatment with n-nitroso-n-methylurea ( cas : 684 - 93 - 5 ) and <target> testosterone propionate </target> [ ( tp ) cas : 57 - 85 - 2 ] , and most of the tumor-bearing rat manifest metastatic lesion .",
        "D043343\tChemical\tTP\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable prostate adenocarcinoma ( pa ) follow treatment with n-nitroso-n-methylurea ( cas : 684 - 93 - 5 ) and testosterone propionate [ ( <target> tp </target> ) cas : 57 - 85 - 2 ] , and most of the tumor-bearing rat manifest metastatic lesion .",
        "D009369\tDisease\ttumor\tMore than 50 % of lobund-wistar ( l-w ) strain rat develop large , palpable prostate adenocarcinoma ( pa ) follow treatment with n-nitroso-n-methylurea ( cas : 684 - 93 - 5 ) and testosterone propionate [ ( tp ) cas : 57 - 85 - 2 ] , and most of the <target> tumor </target> -bearing rat manifest metastatic lesion .",
        "D011471\tDisease\tPA\twithin the same timeframe , no l-w rat develop a similar palpable <target> pa </target> when treat only with tp .",
        "D043343\tChemical\tTP\twithin the same timeframe , no l-w rat develop a similar palpable pa when treat only with <target> tp </target> .",
        "D043343\tChemical\tTP\tin l-w rat , <target> tp </target> act as a tumor enhancement agent , with primary emphasis on the development of prostate cancer .",
        "D009369\tDisease\ttumor\tin l-w rat , tp act as a <target> tumor </target> enhancement agent , with primary emphasis on the development of prostate cancer .",
        "D011471\tDisease\tprostate cancer\tin l-w rat , tp act as a tumor enhancement agent , with primary emphasis on the development of <target> prostate cancer </target> ."
    ]
}